ClinicalTrials.gg
Drug

Vinorelbine clinical trials

Also written KW-2307.

Includes 1 study of Liposomal Vinorelbine Tartrate.

studies test it
226
open now
11
in phase 3
40
first study started
1994

How each study uses Vinorelbine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Vinorelbine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Dec 1994 · NAVELBINE · NDA 020388 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Vinorelbine
112
Navelbine
60
vinorelbine tartrate
53
vinorelbine ditartrate
12
NVB
11

Development codes

KW-2307
3
NSC-608210
1
ANX-530
1

In one entry with another drug

Given together, or one or the other

Vinorelbine plus cisplatin
2
Lapatinib, Vinorelbine
2

Studies by the year they started

225 studies that test it; most in 2001 (15)

Studies that test Vinorelbine, by start year
YearStudies
19941
19961
19974
19986
19999
20007
200115
200211
200313
200412
20058
20067
200713
200815
20097
20108
201110
20128
20132
20142
20154
201613
20179
20185
20195
20206
20216
20224
20234
20246
20253
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
38
Phase 2
154
Phase 3
40
Phase 4
4
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 33 · Other 193

Fudan University (8) · Hellenic Oncology Research Group (8) · Dana-Farber Cancer Institute (7) · Alliance for Clinical Trials in Oncology (6) · Children's Oncology Group (6) · SWOG Cancer Research Network (6) · Memorial Sloan Kettering Cancer Center (5) · University of Washington (5)

Often tested with

Tested in the same studies.

Gemcitabine (46) · Cisplatin (29) · Docetaxel (29) · Capecitabine (28) · Paclitaxel (23) · Trastuzumab (21) · Carboplatin (18) · Cyclophosphamide (14)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 17 phase 3 studies under way

Vinorelbine is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 6

Studies that test Vinorelbine.

Studies

Open first, then newest update. How each study uses Vinorelbine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 226

See all 226 studies that test Vinorelbine →

Given beside what is tested · 83 — Vinorelbine is usual care or a partner of the new treatment

Showing 20 of 83.

As the comparator · 54 — what is tested is compared with Vinorelbine

Showing 20 of 54.

Codes

What other systems call Vinorelbine · ClinicalTrials.gg INT006672

  • MeSH (NLM) D000077235VinorelbineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) Q6C979R91YVINORELBINEConfirmed FDA, NLM, Wikidata
  • RxNorm 39541Confirmed FDA, Wikidata
  • Wikidata Q420532vinorelbineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1275VinorelbineOne source FDA
  • DrugBank DB00361One source Wikidata

Also registered as vinorelbine tartrate (UNII 253GQW851Q · RxNorm 114527).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.